These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27852111)

  • 21. 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as inhibitors of full-length RORγt.
    Lao C; Zhou X; Chen H; Wei F; Huang Z; Bai C
    Bioorg Chem; 2019 Sep; 90():103077. PubMed ID: 31323598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo regulation of gene expression and T helper type 17 differentiation by RORγt inverse agonists.
    Skepner J; Trocha M; Ramesh R; Qu XA; Schmidt D; Baloglu E; Lobera M; Davis S; Nolan MA; Carlson TJ; Hill J; Ghosh S; Sundrud MS; Yang J
    Immunology; 2015 Jul; 145(3):347-56. PubMed ID: 25604624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists.
    Lu Z; Duan JJ; Xiao H; Neels J; Wu DR; Weigelt CA; Sack JS; Khan J; Ruzanov M; An Y; Yarde M; Karmakar A; Vishwakrishnan S; Baratam V; Shankarappa H; Vanteru S; Babu V; Basha M; Kumar Gupta A; Kumaravel S; Mathur A; Zhao Q; Salter-Cid LM; Carter PH; Murali Dhar TG
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2265-2269. PubMed ID: 31257087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
    Saito Y; Kagami S; Sanayama Y; Ikeda K; Suto A; Kashiwakuma D; Furuta S; Iwamoto I; Nonaka K; Ohara O; Nakajima H
    Arthritis Rheumatol; 2014 May; 66(5):1185-94. PubMed ID: 24782182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγt.
    Kummer DA; Cummings MD; Abad M; Barbay J; Castro G; Wolin R; Kreutter KD; Maharoof U; Milligan C; Nishimura R; Pierce J; Schalk-Hihi C; Spurlino J; Urbanski M; Venkatesan H; Wang A; Woods C; Xue X; Edwards JP; Fourie AM; Leonard K
    Bioorg Med Chem Lett; 2017 May; 27(9):2047-2057. PubMed ID: 28318945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The emerging landscape of RORγt biology.
    Lee JS; Cua DJ
    Immunity; 2014 Apr; 40(4):451-2. PubMed ID: 24745326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist.
    Schnute ME; Wennerstål M; Alley J; Bengtsson M; Blinn JR; Bolten CW; Braden T; Bonn T; Carlsson B; Caspers N; Chen M; Choi C; Collis LP; Crouse K; Färnegårdh M; Fennell KF; Fish S; Flick AC; Goos-Nilsson A; Gullberg H; Harris PK; Heasley SE; Hegen M; Hromockyj AE; Hu X; Husman B; Janosik T; Jones P; Kaila N; Kallin E; Kauppi B; Kiefer JR; Knafels J; Koehler K; Kruger L; Kurumbail RG; Kyne RE; Li W; Löfstedt J; Long SA; Menard CA; Mente S; Messing D; Meyers MJ; Napierata L; Nöteberg D; Nuhant P; Pelc MJ; Prinsen MJ; Rhönnstad P; Backström-Rydin E; Sandberg J; Sandström M; Shah F; Sjöberg M; Sundell A; Taylor AP; Thorarensen A; Trujillo JI; Trzupek JD; Unwalla R; Vajdos FF; Weinberg RA; Wood DC; Xing L; Zamaratski E; Zapf CW; Zhao Y; Wilhelmsson A; Berstein G
    J Med Chem; 2018 Dec; 61(23):10415-10439. PubMed ID: 30130103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors.
    Wang Y; Cai W; Zhang G; Yang T; Liu Q; Cheng Y; Zhou L; Ma Y; Cheng Z; Lu S; Zhao YG; Zhang W; Xiang Z; Wang S; Yang L; Wu Q; Orband-Miller LA; Xu Y; Zhang J; Gao R; Huxdorf M; Xiang JN; Zhong Z; Elliott JD; Leung S; Lin X
    Bioorg Med Chem; 2014 Jan; 22(2):692-702. PubMed ID: 24388993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural States of RORγt: X-ray Elucidation of Molecular Mechanisms and Binding Interactions for Natural and Synthetic Compounds.
    Kallen J; Izaac A; Be C; Arista L; Orain D; Kaupmann K; Guntermann C; Hoegenauer K; Hintermann S
    ChemMedChem; 2017 Jul; 12(13):1014-1021. PubMed ID: 28590087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of RORγt-overexpressing T cells in the development of autoimmune arthritis in mice.
    Kondo Y; Yao Z; Tahara M; Iizuka M; Yokosawa M; Kaneko S; Segawa S; Tsuboi H; Yoh K; Takahashi S; Matsumoto I; Sumida T
    Arthritis Res Ther; 2015 Apr; 17(1):105. PubMed ID: 25928901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
    Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
    J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-6-mediated Th17 differentiation through RORγt is essential for the initiation of experimental autoimmune myocarditis.
    Yamashita T; Iwakura T; Matsui K; Kawaguchi H; Obana M; Hayama A; Maeda M; Izumi Y; Komuro I; Ohsugi Y; Fujimoto M; Naka T; Kishimoto T; Nakayama H; Fujio Y
    Cardiovasc Res; 2011 Sep; 91(4):640-8. PubMed ID: 21622681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel benzenediamine derivative FC99 ameliorates zymosan-induced arthritis by inhibiting RORγt expression and Th17 cell differentiation.
    Ji J; Dou H; Li X; Song Y; Li X; Li E; Tan R; Hou Y
    Acta Biochim Biophys Sin (Shanghai); 2014 Oct; 46(10):829-36. PubMed ID: 25187413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of etanercept on the expression of markers of T helper 17 cells and their precursors in skin lesions of patients with psoriasis vulgaris.
    Antiga E; Volpi W; Chiarini C; Cardilicchia E; Filì L; Manuelli C; Parrochi P; Fabbri P; Caproni M
    Int J Immunopathol Pharmacol; 2010; 23(3):767-74. PubMed ID: 20943046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yin-Yang Regulation of RORγt Protein Complex in Th17 Differentiation.
    Gao W; Wu Y; Tian Y; Ni B
    Int Rev Immunol; 2015; 34(4):295-304. PubMed ID: 25340306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of N-indanyl benzamides as potent RORγt inverse agonists.
    Tian J; Sun N; Yu M; Gu X; Xie Q; Shao L; Liu J; Liu L; Wang Y
    Eur J Med Chem; 2019 Apr; 167():37-48. PubMed ID: 30743096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR-induced cytokines promote effective proinflammatory natural Th17 cell responses.
    Massot B; Michel ML; Diem S; Ohnmacht C; Latour S; Dy M; Eberl G; Leite-de-Moraes MC
    J Immunol; 2014 Jun; 192(12):5635-42. PubMed ID: 24808372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signaling Pathways and Epigenetic Regulations in the Control of RORγt Expression in T Helper 17 Cells.
    Tian Y; Wu Y; Ni B
    Int Rev Immunol; 2015; 34(4):305-17. PubMed ID: 24801756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6-Substituted quinolines as RORγt inverse agonists.
    Barbay JK; Cummings MD; Abad M; Castro G; Kreutter KD; Kummer DA; Maharoof U; Milligan C; Nishimura R; Pierce J; Schalk-Hihi C; Spurlino J; Tanis VM; Urbanski M; Venkatesan H; Wang A; Woods C; Wolin R; Xue X; Edwards JP; Fourie AM; Leonard K
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5277-5283. PubMed ID: 29079472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulated development of IL-17- and IL-21-expressing follicular helper T cells and increased germinal center formation in the absence of RORγt.
    Wichner K; Stauss D; Kampfrath B; Krüger K; Müller G; Rehm A; Lipp M; Höpken UE
    FASEB J; 2016 Feb; 30(2):761-74. PubMed ID: 26499265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.